Literature DB >> 10091221

Role of antioxidants in gastric mucosal damage induced by indomethacin in rats.

A Hassan1, E Martin, P Puig-Parellada.   

Abstract

Reactive oxygen species play a role in the formation of gastric lesions induced by nonsteroidal antiinflammatory drugs. The present study was undertaken to determine whether endogenous antioxidants in gastric mucosa can protect it against the damaging effects of oxygen free radicals. This study examine oxygen free radical production (superoxide anions and hydrogen peroxide), gastric mucosa antioxidant defense mechanisms (glutathione, catalase, superoxide dismutase), the lesion-inducing effects of the generated oxygen free radicals (vascular permeability, lipid peroxidation) and gastric ulceration in rats treated orally with indomethacin at 10 mg/kg at 2 and 6 h after drug administration. Two hours after administration of the antiinflammatory drug, there was a sharp increase in production of oxygen free radicals in the gastric mucosa with no alteration in other parameters examined. Six hours after indomethacin administration the production of oxygen free radicals returned to basal levels, but there was a high degree of gastric ulceration and a significant increase in lipid peroxidation and vascular permeability together with decreases of 45% in glutathione concentration and 30% in catalase relative to the control group. These results suggest that like plasma, the gastric mucosa has an antioxidant capacity and only when this capacity is exhausted are the lesive effects of the oxygen free radicals manifested.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10091221     DOI: 10.1358/mf.1998.20.10.487540

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  8 in total

1.  Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy.

Authors:  Timothy R Koch; Ann Petro; Marcus Darrabie; Emmanuel C Opara
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug.

Authors:  Mari Hagiwara; Keiko Kataoka; Hideki Arimochi; Tomomi Kuwahara; Haruyuki Nakayama; Yoshinari Ohnishi
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 3.  Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers.

Authors:  Halis Suleyman; Abdulmecit Albayrak; Mehmet Bilici; Elif Cadirci; Zekai Halici
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

4.  Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin.

Authors:  O Pastoris; M Verri; F Boschi; O Kastsiuchenka; B Balestra; F Pace; M Tonini; G Natale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-11       Impact factor: 3.000

5.  Biological and histopathological investigations of moclobemide on injured ovarian tissue following induction of ischemia-reperfusion in rats.

Authors:  Metin Ingec; Muhammet Calik; Cemal Gundogdu; Ali Kurt; Mehmet Yilmaz; Unal Isaoglu; Suleyman Salman; Fatih Akcay; Halis Suleyman
Journal:  Int J Fertil Steril       Date:  2012-06-19

6.  Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue.

Authors:  Hakan Dursun; Mehmet Bilici; Fatih Albayrak; Cengiz Ozturk; Mustafa B Saglam; Hamit H Alp; Halis Suleyman
Journal:  BMC Gastroenterol       Date:  2009-05-20       Impact factor: 3.067

7.  Benzimidazole derivatives: search for GI-friendly anti-inflammatory analgesic agents.

Authors:  Monika Gaba; Punam Gaba; Deepika Uppal; Neelima Dhingra; Malkeet Singh Bahia; Om Silakari; Chander Mohan
Journal:  Acta Pharm Sin B       Date:  2015-06-25       Impact factor: 11.413

8.  Anti-Inflammation Property of Syzygium cumini (L.) Skeels on Indomethacin-Induced Acute Gastric Ulceration.

Authors:  Lanchakon Chanudom; Jitbanjong Tangpong
Journal:  Gastroenterol Res Pract       Date:  2015-11-08       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.